Inger Rosner is an Urologist in Fairfax, Virginia. Dr. Rosner is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. Her top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Prostatectomy, and Nephrectomy. Dr. Rosner is currently accepting new patients.

Dr. Channing J. Paller is a medical oncologist at Sibley Memorial Hospital and a professor of oncology at the Johns Hopkins University School of Medicine. She practices out of the Prostate Cancer Multidisciplinary Clinic at Sibley Memorial Hospital in Washington, D.C., and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, MD. Dr. Paller has expertise in prostate, bladder, kidney, and testicular cancer. Dr. Paller earned her medical degree from Harvard Medical School and completed a residency in internal medicine, followed by a fellowship in hematology and oncology at Johns Hopkins University School of Medicine. In addition, Dr. Paller completed a rotation with the chief of the Investigational Drug Branch at the National Cancer Institute (NCI) Cancer Therapy Evaluation Program and a rotation with the associate director for regulatory science in the Office of Oncology Drug Products at the Food and Drug Administration. She also completed rotations at the Weizmann Institute of Israel’s Department of Biological Regulation and McCord Hospital in South Africa, where she participated in the Harvard AIDS project. In 2016, Dr. Paller was one of only five oncologists awarded the NCI Mentored Patient-Oriented Research Career Development Award. In 2015, she received the 2015 Passano Clinician Scientist Award for early-stage research that is already making a contribution to science. Earlier in her career, she was selected for both a 2011-2012 Young Investigator Award by the American Society of Clinical Oncology and for the 2011-12 Eastern Cooperative Oncology Group Paul Carbone Award. Dr. Paller is a member of the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Paller’s research focuses on evaluating new therapies for prostate cancer, particularly combination therapies that engage the immune system. She is the principal investigator on two multi-site clinical trials and was the first author on the NCI Investigational Drug Steering Committee publication, “Consensus Recommendations on the Phase I Combination Clinical Trials of the Clinical Trial Design Task Force.” Dr. Paller was the chair for the oral abstract session on genitourinary cancer at the 2015 Annual Meeting of the American Society of Clinical Oncology and she is currently funded by an NCI immunotherapy grant to look at combination therapies that link standard of care therapy with inhibition of transforming growth factor beta in prostate cancer. She is also opening trials of vitamin C with chemotherapy in prostate cancer and of mistletoe in all solid tumors. Dr. Paller is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. Her top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Hormone Replacement Therapy (HRT), and Prostatectomy.

Curtiland Deville, MD, is the Medical Director of the Johns Hopkins Proton Therapy Center, Clinical Director of Radiation Oncology at Sibley Memorial Hospital, co-director of the Kimmel Cancer Center Prostate Multidisciplinary Clinic at Sibley Memorial Hospital and an Associate Professor at the Johns Hopkins University School of Medicine. Dr. Deville is an expert in proton therapy and a leader in several institutional and national clinical trials. He treats genitourinary malignancies, including prostate cancer, and soft tissue sarcomas, and is dedicated to creating individualized treatment plans for each patient. His research interests involve better targeting tumors through proton and photon therapies and reducing radiation to healthy tissues. He analyzes toxicity rates with modern radiation techniques and uses the most advanced technology for his patients’ care. Dr. Deville is also a Senior Editor for Advances in Radiation Oncology, as well as a reviewer for several journals that focus on radiation oncology. He is an expert on physician workforce diversity and widely published in the field. He is the immediate past Chair of the American Society of Radiation Oncology's Committee on Health Equity, Diversity and Inclusion and Chair of the American Society of Clinical Oncology’s Diversity in Oncology Subcommittee. LinkedIn https://www.linkedin.com/in/curtiland-deville-37133136. Dr. Deville is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Myxoid Liposarcoma, Liposarcoma, and Prostatectomy.

Dr. Mark Markowski is a medical oncologist at the Kimmel Cancer Center at Sibley Memorial Hospital, as well as an Associate Professor in the Department of Oncology at Johns Hopkins University School of Medicine. Dr. Markowski participates in multidisciplinary clinics at Sibley and The Johns Hopkins Hospital, and sees patients in the genitourinary clinics of both hospitals. Dr. Markowski treats numerous types of cancers, with a specialty in prostate and kidney cancers. Dr. Markowski earned his medical degree and Ph.D. in tumor biology at Georgetown University School of Medicine. He completed a residency in internal medicine at Columbia University, followed by a medical oncology fellowship at Johns Hopkins Hospital. Dr. Markowski previously served as a research associate at the Lombardi Comprehensive Cancer Center at Georgetown University. His research interests focus on early phase drug development for prostate cancer, as well a non-castrating therapies for patients with metastatic disease. Dr. Markowski is currently conducting research with funding from a Department of Defense Prostate Cancer Research Program Award and a Challenge Award from the Prostate Cancer Foundation, which focuses on new treatment strategies for prostate cancer patients. Dr. Markowski is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Wilms Tumor, Hormone Replacement Therapy (HRT), and Prostatectomy.

Eric Choe is an Urologist in Fairfax, Virginia. Dr. Choe is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are UPJ Obstruction, Enlarged Prostate (BPH), Hydronephrosis, Ureteroscopy, and Prostatectomy. Dr. Choe is currently accepting new patients.

John Basile is an Urologist in Fairfax, Virginia. Dr. Basile is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Bladder Stones, and Enlarged Prostate (BPH).

Simon Chung is an Urologist in Fairfax, Virginia. Dr. Chung is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Muscle Invasive Bladder Cancer, Familial Prostate Cancer, Prostate Cancer, Vasectomy, and Reconstructive Urology Surgery. Dr. Chung is currently accepting new patients.

Daniel Kim is a Radiation Oncologist in Fairfax, Virginia. Dr. Kim is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Metastatic Brain Tumor, Brain Tumor, and Prostatectomy. Dr. Kim is currently accepting new patients.

Brett Holt is an Urologist in Fairfax, Virginia. Dr. Holt is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, UPJ Obstruction, Ureteroscopy, and Reconstructive Urology Surgery. Dr. Holt is currently accepting new patients.

Mustafa Abugideiri is a Radiation Oncologist in Fairfax, Virginia. Dr. Abugideiri is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, and Breast Cancer. Dr. Abugideiri is currently accepting new patients.

Avani Rao is a Radiation Oncologist in Fairfax, Virginia. Dr. Rao is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. Her top areas of expertise are Endometrial Stromal Sarcoma, Endometrial Cancer, Metastatic Brain Tumor, and Familial Prostate Cancer. Dr. Rao is currently accepting new patients.

Edmond Paquette is an Urologist in Falls Church, Virginia. Dr. Paquette is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Muscle Invasive Bladder Cancer, Prostate Cancer, Familial Prostate Cancer, Ureteroscopy, and Reconstructive Urology Surgery. Dr. Paquette is currently accepting new patients.

Tobias Chapman is a Radiation Oncologist in Falls Church, Virginia. Dr. Chapman is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, HER-2 Positive Breast Cancer, and Metastatic Brain Tumor. Dr. Chapman is currently accepting new patients.

Lonika Majithia is a Radiation Oncologist in Falls Church, Virginia. Dr. Majithia is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. Her top areas of expertise are Breast Cancer, Metastatic Brain Tumor, Cervical Cancer, and Neuroendocrine Carcinoma of the Cervix. Dr. Majithia is currently accepting new patients.

Jeanny Aragon-Ching is an Oncologist and a Hematologist in Alexandria, Virginia. Dr. Aragon-Ching is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. Her top areas of expertise are Prostate Cancer, Urothelial Cancer, Bladder Cancer, Orchiectomy, and Prostatectomy. Dr. Aragon-Ching is currently accepting new patients.

Anatoly Dritschilo is a Radiation Oncologist in Washington, Washington, D.c.. Dr. Dritschilo is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Medulloblastoma, and Embryonal Tumor with Multilayered Rosettes.

Peter Pinto is an Urologist in Bethesda, Maryland. Dr. Pinto is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Enlarged Prostate (BPH), Prostatectomy, and Nephrectomy.

Bradford Wood is an Interventional Radiologist in Bethesda, Maryland. Dr. Wood is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Liver Cancer, Enlarged Prostate (BPH), Liver Embolization, and Prostatectomy.

James Gulley is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Gulley is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Olfactory Neuroblastoma, Chordoma, Urothelial Cancer, and Orchiectomy.

Ravi Madan is a Hematologist Oncology provider in Washington, Washington, D.c.. Dr. Madan is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Chordoma, Medullary Thyroid Carcinoma, Orchiectomy, and Prostatectomy.